NZ700644A - Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof - Google Patents

Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof

Info

Publication number
NZ700644A
NZ700644A NZ700644A NZ70064414A NZ700644A NZ 700644 A NZ700644 A NZ 700644A NZ 700644 A NZ700644 A NZ 700644A NZ 70064414 A NZ70064414 A NZ 70064414A NZ 700644 A NZ700644 A NZ 700644A
Authority
NZ
New Zealand
Prior art keywords
derivatives
application
thiochromeno
quinolin
novel
Prior art date
Application number
NZ700644A
Inventor
Huang Hsu-Shan
Chen Tsung-Chih
Yu Dah-Shyong
Original Assignee
Nat Defense Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Defense Medical Ct filed Critical Nat Defense Medical Ct
Priority to NZ700644A priority Critical patent/NZ700644A/en
Publication of NZ700644A publication Critical patent/NZ700644A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a series of novel thiochromeno[2,3-c]quinolin-12-one derivatives. Further, the invention also provides the preparation method and application of said derivatives, said application comprises: said derivatives with treating effective amount are prepared into pharmaceutical compositions for inhibition of topoisomerase type I and II, inhibition of cancer cell growth, further treating cancer.
NZ700644A 2014-10-02 2014-10-02 Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof NZ700644A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ700644A NZ700644A (en) 2014-10-02 2014-10-02 Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ700644A NZ700644A (en) 2014-10-02 2014-10-02 Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof

Publications (1)

Publication Number Publication Date
NZ700644A true NZ700644A (en) 2015-11-27

Family

ID=55405612

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ700644A NZ700644A (en) 2014-10-02 2014-10-02 Novel thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof

Country Status (1)

Country Link
NZ (1) NZ700644A (en)

Similar Documents

Publication Publication Date Title
AU2014241199A8 (en) Compositions and methods for enhancing plant growth
AU2015237050A8 (en) Quinoline derivatives as SMO inhibitors
GEP20207160B (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
WO2018067512A8 (en) Spirocyclic compounds
NZ731789A (en) Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
EP3800248A3 (en) Crispr-cas-related methods, compositions and components for cancer immunotherapy
WO2016044189A8 (en) Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
EP3473624A4 (en) Novel imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer
MX2016002544A (en) Compounds useful as immunomodulators.
PH12017500358A1 (en) Cytotoxic benzodiazepine derivatives
MX2019010514A (en) Compositions and methods for improving tomato production.
GEP20186933B (en) Substituted dihydroisoquinoline compounds
EP3342858A4 (en) Ror1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ror1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating diseases by using ror1-positive mesenchymal stem cells
MX2017004618A (en) Heparan sulfate biosynthesis inhibitors for the treatment of diseases.
EP3325608A4 (en) Methods and microorganisms for the production of 1,3-butanediol
MX2016009663A (en) Icariin derivatives.
WO2015123449A3 (en) Compositions and methods of using microrna inhibitors
MX2016014436A (en) Heterocyclyl-butanamide derivatives.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EP3539951A4 (en) Novel pyrimidine compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer and inflammatory diseases
MX2020000135A (en) New quinolinone compounds.
EP3638218A4 (en) Compositions and methods targeting complement component 3 for inhibiting tumor growth
EP3694331A4 (en) Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
UA117318C2 (en) 7-(morpholinyl)-2-(n-piperazinyl) methyl thieno[2, 3-c]pyridine derivatives as anticancer drugs
MX2018004474A (en) Anti-cd43 antibody and use thereof for cancer treatment.

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: NATIONAL DEFENSE MEDICAL CENTER, TW

Effective date: 20150806

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2019 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP.

Effective date: 20180903

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2020 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP.

Effective date: 20190903

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2021 BY NORTH AMERICA INTELLECTUAL PROPERTY CORP.

Effective date: 20200909

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2022 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS

Effective date: 20220321

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 OCT 2023 BY A.P.T. PATENT AND TRADE MARK ATTORNEYS

Effective date: 20230329